Mitral Regurgitation Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mitral Regurgitation Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Primary Mitral Regurgitation
1.2.3 Secondary Mitral Regurgitation
1.3 Market by Application
1.3.1 Global Mitral Regurgitation Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Transapical
1.3.3 Via Stock and Via Interstitial
1.3.4 Right Internal Jugular Vein
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mitral Regurgitation Market Perspective (2017-2028)
2.2 Mitral Regurgitation Growth Trends by Region
2.2.1 Mitral Regurgitation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mitral Regurgitation Historic Market Size by Region (2017-2022)
2.2.3 Mitral Regurgitation Forecasted Market Size by Region (2023-2028)
2.3 Mitral Regurgitation Market Dynamics
2.3.1 Mitral Regurgitation Industry Trends
2.3.2 Mitral Regurgitation Market Drivers
2.3.3 Mitral Regurgitation Market Challenges
2.3.4 Mitral Regurgitation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mitral Regurgitation Players by Revenue
3.1.1 Global Top Mitral Regurgitation Players by Revenue (2017-2022)
3.1.2 Global Mitral Regurgitation Revenue Market Share by Players (2017-2022)
3.2 Global Mitral Regurgitation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mitral Regurgitation Revenue
3.4 Global Mitral Regurgitation Market Concentration Ratio
3.4.1 Global Mitral Regurgitation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mitral Regurgitation Revenue in 2021
3.5 Mitral Regurgitation Key Players Head office and Area Served
3.6 Key Players Mitral Regurgitation Product Solution and Service
3.7 Date of Enter into Mitral Regurgitation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mitral Regurgitation Breakdown Data by Type
4.1 Global Mitral Regurgitation Historic Market Size by Type (2017-2022)
4.2 Global Mitral Regurgitation Forecasted Market Size by Type (2023-2028)
5 Mitral Regurgitation Breakdown Data by Application
5.1 Global Mitral Regurgitation Historic Market Size by Application (2017-2022)
5.2 Global Mitral Regurgitation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mitral Regurgitation Market Size (2017-2028)
6.2 North America Mitral Regurgitation Market Size by Country (2017-2022)
6.3 North America Mitral Regurgitation Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Mitral Regurgitation Market Size (2017-2028)
7.2 Europe Mitral Regurgitation Market Size by Country (2017-2022)
7.3 Europe Mitral Regurgitation Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mitral Regurgitation Market Size (2017-2028)
8.2 Asia-Pacific Mitral Regurgitation Market Size by Country (2017-2022)
8.3 Asia-Pacific Mitral Regurgitation Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Mitral Regurgitation Market Size (2017-2028)
9.2 Latin America Mitral Regurgitation Market Size by Country (2017-2022)
9.3 Latin America Mitral Regurgitation Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mitral Regurgitation Market Size (2017-2028)
10.2 Middle East & Africa Mitral Regurgitation Market Size by Country (2017-2022)
10.3 Middle East & Africa Mitral Regurgitation Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Company Detail
11.1.2 Edwards Lifesciences Business Overview
11.1.3 Edwards Lifesciences Mitral Regurgitation Introduction
11.1.4 Edwards Lifesciences Revenue in Mitral Regurgitation Business (2017-2022)
11.1.5 Edwards Lifesciences Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Mitral Regurgitation Introduction
11.2.4 Abbott Revenue in Mitral Regurgitation Business (2017-2022)
11.2.5 Abbott Recent Development
11.3 CardioSolution
11.3.1 CardioSolution Company Detail
11.3.2 CardioSolution Business Overview
11.3.3 CardioSolution Mitral Regurgitation Introduction
11.3.4 CardioSolution Revenue in Mitral Regurgitation Business (2017-2022)
11.3.5 CardioSolution Recent Development
11.4 NeoChord
11.4.1 NeoChord Company Detail
11.4.2 NeoChord Business Overview
11.4.3 NeoChord Mitral Regurgitation Introduction
11.4.4 NeoChord Revenue in Mitral Regurgitation Business (2017-2022)
11.4.5 NeoChord Recent Development
11.5 Mitralign
11.5.1 Mitralign Company Detail
11.5.2 Mitralign Business Overview
11.5.3 Mitralign Mitral Regurgitation Introduction
11.5.4 Mitralign Revenue in Mitral Regurgitation Business (2017-2022)
11.5.5 Mitralign Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Mitral Regurgitation Introduction
11.6.4 Medtronic Revenue in Mitral Regurgitation Business (2017-2022)
11.6.5 Medtronic Recent Development
11.7 Boston Scientific
11.7.1 Boston Scientific Company Detail
11.7.2 Boston Scientific Business Overview
11.7.3 Boston Scientific Mitral Regurgitation Introduction
11.7.4 Boston Scientific Revenue in Mitral Regurgitation Business (2017-2022)
11.7.5 Boston Scientific Recent Development
11.8 Mitralix
11.8.1 Mitralix Company Detail
11.8.2 Mitralix Business Overview
11.8.3 Mitralix Mitral Regurgitation Introduction
11.8.4 Mitralix Revenue in Mitral Regurgitation Business (2017-2022)
11.8.5 Mitralix Recent Development
11.9 Shanghai Hanyu Medical Technology
11.9.1 Shanghai Hanyu Medical Technology Company Detail
11.9.2 Shanghai Hanyu Medical Technology Business Overview
11.9.3 Shanghai Hanyu Medical Technology Mitral Regurgitation Introduction
11.9.4 Shanghai Hanyu Medical Technology Revenue in Mitral Regurgitation Business (2017-2022)
11.9.5 Shanghai Hanyu Medical Technology Recent Development
11.10 Valgen Holding Corporation
11.10.1 Valgen Holding Corporation Company Detail
11.10.2 Valgen Holding Corporation Business Overview
11.10.3 Valgen Holding Corporation Mitral Regurgitation Introduction
11.10.4 Valgen Holding Corporation Revenue in Mitral Regurgitation Business (2017-2022)
11.10.5 Valgen Holding Corporation Recent Development
11.11 NeoChord
11.11.1 NeoChord Company Detail
11.11.2 NeoChord Business Overview
11.11.3 NeoChord Mitral Regurgitation Introduction
11.11.4 NeoChord Revenue in Mitral Regurgitation Business (2017-2022)
11.11.5 NeoChord Recent Development
11.12 CoreMedic
11.12.1 CoreMedic Company Detail
11.12.2 CoreMedic Business Overview
11.12.3 CoreMedic Mitral Regurgitation Introduction
11.12.4 CoreMedic Revenue in Mitral Regurgitation Business (2017-2022)
11.12.5 CoreMedic Recent Development
11.13 Babic Chord
11.13.1 Babic Chord Company Detail
11.13.2 Babic Chord Business Overview
11.13.3 Babic Chord Mitral Regurgitation Introduction
11.13.4 Babic Chord Revenue in Mitral Regurgitation Business (2017-2022)
11.13.5 Babic Chord Recent Development
11.14 Gore Medical
11.14.1 Gore Medical Company Detail
11.14.2 Gore Medical Business Overview
11.14.3 Gore Medical Mitral Regurgitation Introduction
11.14.4 Gore Medical Revenue in Mitral Regurgitation Business (2017-2022)
11.14.5 Gore Medical Recent Development
11.15 Valtech Cardio
11.15.1 Valtech Cardio Company Detail
11.15.2 Valtech Cardio Business Overview
11.15.3 Valtech Cardio Mitral Regurgitation Introduction
11.15.4 Valtech Cardio Revenue in Mitral Regurgitation Business (2017-2022)
11.15.5 Valtech Cardio Recent Development
11.16 Transcardiac
11.16.1 Transcardiac Company Detail
11.16.2 Transcardiac Business Overview
11.16.3 Transcardiac Mitral Regurgitation Introduction
11.16.4 Transcardiac Revenue in Mitral Regurgitation Business (2017-2022)
11.16.5 Transcardiac Recent Development
11.17 ChoRe
11.17.1 ChoRe Company Detail
11.17.2 ChoRe Business Overview
11.17.3 ChoRe Mitral Regurgitation Introduction
11.17.4 ChoRe Revenue in Mitral Regurgitation Business (2017-2022)
11.17.5 ChoRe Recent Development
11.18 AVVIE
11.18.1 AVVIE Company Detail
11.18.2 AVVIE Business Overview
11.18.3 AVVIE Mitral Regurgitation Introduction
11.18.4 AVVIE Revenue in Mitral Regurgitation Business (2017-2022)
11.18.5 AVVIE Recent Development
11.19 Cardiovalve
11.19.1 Cardiovalve Company Detail
11.19.2 Cardiovalve Business Overview
11.19.3 Cardiovalve Mitral Regurgitation Introduction
11.19.4 Cardiovalve Revenue in Mitral Regurgitation Business (2017-2022)
11.19.5 Cardiovalve Recent Development
11.20 HighLife SAS
11.20.1 HighLife SAS Company Detail
11.20.2 HighLife SAS Business Overview
11.20.3 HighLife SAS Mitral Regurgitation Introduction
11.20.4 HighLife SAS Revenue in Mitral Regurgitation Business (2017-2022)
11.20.5 HighLife SAS Recent Development
11.21 Neovasc
11.21.1 Neovasc Company Detail
11.21.2 Neovasc Business Overview
11.21.3 Neovasc Mitral Regurgitation Introduction
11.21.4 Neovasc Revenue in Mitral Regurgitation Business (2017-2022)
11.21.5 Neovasc Recent Development
11.22 MitrAssist Lifesciences
11.22.1 MitrAssist Lifesciences Company Detail
11.22.2 MitrAssist Lifesciences Business Overview
11.22.3 MitrAssist Lifesciences Mitral Regurgitation Introduction
11.22.4 MitrAssist Lifesciences Revenue in Mitral Regurgitation Business (2017-2022)
11.22.5 MitrAssist Lifesciences Recent Development
11.23 Shanghai NewMed Medical
11.23.1 Shanghai NewMed Medical Company Detail
11.23.2 Shanghai NewMed Medical Business Overview
11.23.3 Shanghai NewMed Medical Mitral Regurgitation Introduction
11.23.4 Shanghai NewMed Medical Revenue in Mitral Regurgitation Business (2017-2022)
11.23.5 Shanghai NewMed Medical Recent Development
11.24 Peijia Medical
11.24.1 Peijia Medical Company Detail
11.24.2 Peijia Medical Business Overview
11.24.3 Peijia Medical Mitral Regurgitation Introduction
11.24.4 Peijia Medical Revenue in Mitral Regurgitation Business (2017-2022)
11.24.5 Peijia Medical Recent Development
11.25 MicroPort CardioFlow Medtech
11.25.1 MicroPort CardioFlow Medtech Company Detail
11.25.2 MicroPort CardioFlow Medtech Business Overview
11.25.3 MicroPort CardioFlow Medtech Mitral Regurgitation Introduction
11.25.4 MicroPort CardioFlow Medtech Revenue in Mitral Regurgitation Business (2017-2022)
11.25.5 MicroPort CardioFlow Medtech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Mitral Regurgitation Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Primary Mitral Regurgitation
Table 3. Key Players of Secondary Mitral Regurgitation
Table 4. Global Mitral Regurgitation Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Mitral Regurgitation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Mitral Regurgitation Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Mitral Regurgitation Market Share by Region (2017-2022)
Table 8. Global Mitral Regurgitation Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Mitral Regurgitation Market Share by Region (2023-2028)
Table 10. Mitral Regurgitation Market Trends
Table 11. Mitral Regurgitation Market Drivers
Table 12. Mitral Regurgitation Market Challenges
Table 13. Mitral Regurgitation Market Restraints
Table 14. Global Mitral Regurgitation Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Mitral Regurgitation Market Share by Players (2017-2022)
Table 16. Global Top Mitral Regurgitation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitral Regurgitation as of 2021)
Table 17. Ranking of Global Top Mitral Regurgitation Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Mitral Regurgitation Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mitral Regurgitation Product Solution and Service
Table 21. Date of Enter into Mitral Regurgitation Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mitral Regurgitation Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Mitral Regurgitation Revenue Market Share by Type (2017-2022)
Table 25. Global Mitral Regurgitation Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Mitral Regurgitation Revenue Market Share by Type (2023-2028)
Table 27. Global Mitral Regurgitation Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Mitral Regurgitation Revenue Market Share by Application (2017-2022)
Table 29. Global Mitral Regurgitation Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Mitral Regurgitation Revenue Market Share by Application (2023-2028)
Table 31. North America Mitral Regurgitation Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Mitral Regurgitation Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Mitral Regurgitation Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Mitral Regurgitation Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Mitral Regurgitation Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Mitral Regurgitation Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Mitral Regurgitation Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Mitral Regurgitation Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Mitral Regurgitation Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Mitral Regurgitation Market Size by Country (2023-2028) & (US$ Million)
Table 41. Edwards Lifesciences Company Detail
Table 42. Edwards Lifesciences Business Overview
Table 43. Edwards Lifesciences Mitral Regurgitation Product
Table 44. Edwards Lifesciences Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 45. Edwards Lifesciences Recent Development
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott Mitral Regurgitation Product
Table 49. Abbott Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. CardioSolution Company Detail
Table 52. CardioSolution Business Overview
Table 53. CardioSolution Mitral Regurgitation Product
Table 54. CardioSolution Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 55. CardioSolution Recent Development
Table 56. NeoChord Company Detail
Table 57. NeoChord Business Overview
Table 58. NeoChord Mitral Regurgitation Product
Table 59. NeoChord Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 60. NeoChord Recent Development
Table 61. Mitralign Company Detail
Table 62. Mitralign Business Overview
Table 63. Mitralign Mitral Regurgitation Product
Table 64. Mitralign Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 65. Mitralign Recent Development
Table 66. Medtronic Company Detail
Table 67. Medtronic Business Overview
Table 68. Medtronic Mitral Regurgitation Product
Table 69. Medtronic Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 70. Medtronic Recent Development
Table 71. Boston Scientific Company Detail
Table 72. Boston Scientific Business Overview
Table 73. Boston Scientific Mitral Regurgitation Product
Table 74. Boston Scientific Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 75. Boston Scientific Recent Development
Table 76. Mitralix Company Detail
Table 77. Mitralix Business Overview
Table 78. Mitralix Mitral Regurgitation Product
Table 79. Mitralix Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 80. Mitralix Recent Development
Table 81. Shanghai Hanyu Medical Technology Company Detail
Table 82. Shanghai Hanyu Medical Technology Business Overview
Table 83. Shanghai Hanyu Medical Technology Mitral Regurgitation Product
Table 84. Shanghai Hanyu Medical Technology Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 85. Shanghai Hanyu Medical Technology Recent Development
Table 86. Valgen Holding Corporation Company Detail
Table 87. Valgen Holding Corporation Business Overview
Table 88. Valgen Holding Corporation Mitral Regurgitation Product
Table 89. Valgen Holding Corporation Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 90. Valgen Holding Corporation Recent Development
Table 91. NeoChord Company Detail
Table 92. NeoChord Business Overview
Table 93. NeoChord Mitral RegurgitationProduct
Table 94. NeoChord Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 95. NeoChord Recent Development
Table 96. CoreMedic Company Detail
Table 97. CoreMedic Business Overview
Table 98. CoreMedic Mitral RegurgitationProduct
Table 99. CoreMedic Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 100. CoreMedic Recent Development
Table 101. Babic Chord Company Detail
Table 102. Babic Chord Business Overview
Table 103. Babic Chord Mitral RegurgitationProduct
Table 104. Babic Chord Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 105. Babic Chord Recent Development
Table 106. Gore Medical Company Detail
Table 107. Gore Medical Business Overview
Table 108. Gore Medical Mitral RegurgitationProduct
Table 109. Gore Medical Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 110. Gore Medical Recent Development
Table 111. Valtech Cardio Company Detail
Table 112. Valtech Cardio Business Overview
Table 113. Valtech Cardio Mitral RegurgitationProduct
Table 114. Valtech Cardio Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 115. Valtech Cardio Recent Development
Table 116. Transcardiac Company Detail
Table 117. Transcardiac Business Overview
Table 118. Transcardiac Mitral RegurgitationProduct
Table 119. Transcardiac Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 120. Transcardiac Recent Development
Table 121. ChoRe Company Detail
Table 122. ChoRe Business Overview
Table 123. ChoRe Mitral RegurgitationProduct
Table 124. ChoRe Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 125. ChoRe Recent Development
Table 126. AVVIE Company Detail
Table 127. AVVIE Business Overview
Table 128. AVVIE Mitral RegurgitationProduct
Table 129. AVVIE Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 130. AVVIE Recent Development
Table 131. Cardiovalve Company Detail
Table 132. Cardiovalve Business Overview
Table 133. Cardiovalve Mitral RegurgitationProduct
Table 134. Cardiovalve Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 135. Cardiovalve Recent Development
Table 136. HighLife SAS Company Detail
Table 137. HighLife SAS Business Overview
Table 138. HighLife SAS Mitral RegurgitationProduct
Table 139. HighLife SAS Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 140. HighLife SAS Recent Development
Table 141. Neovasc Company Detail
Table 142. Neovasc Business Overview
Table 143. Neovasc Mitral RegurgitationProduct
Table 144. Neovasc Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 145. Neovasc Recent Development
Table 146. MitrAssist Lifesciences Company Detail
Table 147. MitrAssist Lifesciences Business Overview
Table 148. MitrAssist Lifesciences Mitral RegurgitationProduct
Table 149. MitrAssist Lifesciences Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 150. MitrAssist Lifesciences Recent Development
Table 151. Shanghai NewMed Medical Company Detail
Table 152. Shanghai NewMed Medical Business Overview
Table 153. Shanghai NewMed Medical Mitral RegurgitationProduct
Table 154. Shanghai NewMed Medical Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 155. Shanghai NewMed Medical Recent Development
Table 156. Peijia Medical Company Detail
Table 157. Peijia Medical Business Overview
Table 158. Peijia Medical Mitral RegurgitationProduct
Table 159. Peijia Medical Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 160. Peijia Medical Recent Development
Table 161. MicroPort CardioFlow Medtech Company Detail
Table 162. MicroPort CardioFlow Medtech Business Overview
Table 163. MicroPort CardioFlow Medtech Mitral RegurgitationProduct
Table 164. MicroPort CardioFlow Medtech Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 165. MicroPort CardioFlow Medtech Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mitral Regurgitation Market Share by Type: 2021 VS 2028
Figure 2. Primary Mitral Regurgitation Features
Figure 3. Secondary Mitral Regurgitation Features
Figure 4. Global Mitral Regurgitation Market Share by Application in 2021 & 2028
Figure 5. Transapical Case Studies
Figure 6. Via Stock and Via Interstitial Case Studies
Figure 7. Right Internal Jugular Vein Case Studies
Figure 8. Mitral Regurgitation Report Years Considered
Figure 9. Global Mitral Regurgitation Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Mitral Regurgitation Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Mitral Regurgitation Market Share by Region: 2021 VS 2028
Figure 12. Global Mitral Regurgitation Market Share by Players in 2021
Figure 13. Global Top Mitral Regurgitation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitral Regurgitation as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Mitral Regurgitation Revenue in 2021
Figure 15. North America Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Mitral Regurgitation Market Share by Country (2017-2028)
Figure 17. United States Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Mitral Regurgitation Market Share by Country (2017-2028)
Figure 21. Germany Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Mitral Regurgitation Market Share by Region (2017-2028)
Figure 29. China Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Mitral Regurgitation Market Share by Country (2017-2028)
Figure 37. Mexico Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Mitral Regurgitation Market Share by Country (2017-2028)
Figure 41. Turkey Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Edwards Lifesciences Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 44. Abbott Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 45. CardioSolution Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 46. NeoChord Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 47. Mitralign Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 48. Medtronic Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 49. Boston Scientific Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 50. Mitralix Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 51. Shanghai Hanyu Medical Technology Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 52. Valgen Holding Corporation Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 53. NeoChord Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 54. CoreMedic Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 55. Babic Chord Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 56. Gore Medical Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 57. Valtech Cardio Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 58. Transcardiac Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 59. ChoRe Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 60. AVVIE Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 61. Cardiovalve Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 62. HighLife SAS Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 63. Neovasc Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 64. MitrAssist Lifesciences Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 65. Shanghai NewMed Medical Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 66. Peijia Medical Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 67. MicroPort CardioFlow Medtech Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Industry Market Size
